Cargando…
Chemical Starting Matter for HNF4α Ligand Discovery and Chemogenomics
Hepatocyte nuclear factor 4α (HNF4α) is a ligand-sensing transcription factor and presents as a potential drug target in metabolic diseases and cancer. In humans, mutations in the HNF4α gene cause maturity-onset diabetes of the young (MODY), and the elevated activity of this protein has been associa...
Autores principales: | Meijer, Isabelle, Willems, Sabine, Ni, Xiaomin, Heering, Jan, Chaikuad, Apirat, Merk, Daniel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7660650/ https://www.ncbi.nlm.nih.gov/pubmed/33114319 http://dx.doi.org/10.3390/ijms21217895 |
Ejemplares similares
-
A Consensus Compound/Bioactivity Dataset for Data-Driven Drug Design and Chemogenomics
por: Isigkeit, Laura, et al.
Publicado: (2022) -
The orphan nuclear receptor Nurr1 is responsive to non-steroidal anti-inflammatory drugs
por: Willems, Sabine, et al.
Publicado: (2020) -
Comprehensive Set of Tertiary Complex Structures and Palmitic Acid Binding Provide Molecular Insights into Ligand Design for RXR Isoforms
por: Chaikuad, Apirat, et al.
Publicado: (2020) -
Image-Based Annotation of Chemogenomic Libraries for Phenotypic Screening
por: Tjaden, Amelie, et al.
Publicado: (2022) -
Structural Insights into Plasticity and Discovery
of Remdesivir Metabolite GS-441524 Binding in SARS-CoV-2 Macrodomain
por: Ni, Xiaomin, et al.
Publicado: (2021)